Dose finding study to determine the safety and tolerability of sotatercept (ACE-011) in adults with beta-thalassemia (β-thalassemia)

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-005659-15

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To determine a safe, tolerable and effective dose of sotatercept in adult subjects with RBC transfusion-dependent beta-thalassemia major (including all subtypes)and β thalassemia intermedia, as well as non-transfusion dependent β-thalassemia intermedia.


Critère d'inclusion

  • Subjects with red blood cell (RBC) transfusion dependent β-thalassemia major and β thalassemia intermedia, as well as non-transfusion dependent β-thalassemia intermedia will take part in this study